Compass Wealth Management »

Immunitybio shares owned by Compass Wealth Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Compass Wealth Management from 13F filings

Historical chart of Compass Wealth Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Compass Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Compass Wealth Management

Quarter filed Position value Share count Share price at filing
2026-09-30 $29k 3.1k 9.44

More positions owned by Compass Wealth Management

Broadcom (AVGO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Applied Materials (AMAT)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Advanced Energy Industries (AEIS)
Danaher Corporation (DHR)
V.F. Corporation (VFC)
Spdr Series Trust St Str P500etf (SPYM)
Chevron Corporation (CVX)
Starbucks Corporation (SBUX)
Veeva Sys Cl A Com (VEEV)

View all positions for Compass Wealth Management

Top funds holding Immunitybio

BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
D. E. Shaw & Co
Two Sigma Investments
Geode Capital Management
Susquehanna International
Citadel Advisors
Millennium Management
LMR Partners
Northern Trust
Goldman Sachs Group
UBS Group
Dr. Jeffrey R. Jay, M.D.

View all funds holding Immunitybio